The French National Alliance for Life Sciences and Health AVIESAN Prof. André Syrota Chairman and CEO of Inserm President of Aviesan STOA, Brussels, June.

Slides:

Advertisements

Similar presentations

Why does ERA Need to Flourish

Advertisements

CEACHRUCNRSCPUINRAINRIAINSERMINSTITUT PASTEURIRD ARIISEFSINERISINSTITUT CURIEINSTITUT MINES-TELECOMUNICANCERIRBAIRSNCIRADFONDATION MERIEUX 1 ITMO Cancer.

Vaccination against infectious diseases in man and animal Overview of the FEAMs project proposal for the European Commission (Public Health Programme

EU Presidency National Innovation Office Hungary Ildikó Kovács, PhD Director General International Relations Steering Platform On Research for Western.

Research & Innovation Towards better access to scientific information "Strategy, policy and funding" Copenhagen June 13 th Octavi Quintana Trias Director,

Understanding the Importance of Public Health Public Health 101 [Insert your name and title] [Insert LHD name]

Research and Innovation Research and Innovation An Overview of European Commission Activities on Infectious Diseases Ole Olesen Unit Infectious Diseases.

Keji Adunmo APRE – Agency for the Promotion of European Research Brussels, 29 Sept Funded by the European Commission's Directorate-General for Research.

Professor Dave Delpy Chief Executive of Engineering and Physical Sciences Research Council Research Councils UK Impact Champion Competition vs. Collaboration:

3 rd International Biomedical Research Meeting June 10 th 2011 Résidence de Marigny Pr André Syrota.

AgreenSkills is an open programme of international mobility Supporting talented and experienced young researchers from all disciplines and from all over.

E-Science and Open Access, Data, Science, … a Nordic perspective Sverker Holmgren Director The Nordic e-Science Globalisation Initiative.

Public Research Funding in Health Emergencies – Australian Perspective and Strategies Clive Morris Head, Strategic Policy National Health and Medical Research.

PUBLIC HEALTH INNOVATION AND RESEARCH IN EUROPE AND THE UNITED KINGDOM EXPLORING THE BREADTH OF PUBLIC HEALTH RESEARCH FPH ANNUAL CONFERENCE 2012, CARDIFF.

© Fraunhofer ISI Seite 1 Smoke screens and sacred fires: Translational research and grand challenges in European biomedicine. Etienne Vignola-Gagné Fraunhofer.

Indridi Benediktsson June 2007 International Collaboration in FP7 Health Research Dr. Indridi Benediktsson Directorate Health Horizontal Aspects and Coordination.

Research & Innovation Evolution from IMI1 to IMI2: challenges ahead Elmar Nimmesgern, PhD DG Research & Innovation 1.

Research Infrastructure Policy and Priorities in Australia David de Carvalho Head of Higher Education Group 5 November 2013.

Prof Desmond Sheridan ESC mission To improve the quality of life of the European population by reducing the impact of cardiovascular disease.

Making dementia a European priority Marseille – 17 October 2008 Jean Georges, Executive Director.

1 Institute of Epidemiology and Infectious Diseases Research Activities The L.V. Gromashevsky Institute of Epidemiology and Infectious Diseases Svetlana.

A L I M E N T A T I O N A G R I C U L T U R E E N V I R O N N E M E N T INRA: for the Earth and for Man Public mission oriented research Sustainable agriculture.

Research Infrastructures The Research Infrastructures in FP7.

Research and Innovation Research and Innovation Research and Innovation Research and Innovation Research Infrastructures and Horizon 2020 The EU Framework.

EMERGING AND RE-EMERGING INFECTIOUS DISEASES: A CONTINUOUS CHALLENGE FOR EUROPE STOA - AVIESAN Workshop June 19th 2012, European Parliament, Bruxelles.

John McDougall, President 10 th Annual Re$earch Money Conference, 11 May 2011.

FORESIGHT STUDY Future Trends and Challenges in Pathogenomics JUDITH SIMON & SVEN POMPE PROGRAMME GROUP MUT.

Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Life Sciences, Genomics and Biotechnology for Health.

The National Institute for Agronomic Research  Set up in 1946  A public, scientific and technological establishment  Under the joint authority of the.

Challenges and opportunities in New Zealand’s pharmaceutical scene Kevin Sheehy – Chief Executive, Medicines New Zealand Dalton Kelly – Chief Executive,

Horizon 2020 The EU Framework Programme for Research and Innovation Health, Demographic Change and Wellbeing Lul Raka, NCP for Horizon 2020 – Health.

Director, DG RTD, Directorate International Cooperation

Health environment. Is a health background necessary?

WHY A SCHOOL OF PUBLIC HEALTH IN THE 21ST CENTURY? Pierre FOURNIER Dean, School of Public Health Université de Montréal.

Dr. José M. Millán, PhD Deputy Director of CIBERER Universitary Hospital La Fe, Valencia, Spain Barriers and Challenges in Rare Diseases Research Centre.

Overview of current ANCS activities in relation with IMI Ioana Ispas Advisor for Bioethics, Genomics and Health ANCS.

Where to focus? Horizon 2020 'Health, demographic change and wellbeing' Open Info Day -Horizon 2020 'Health, demographic change and wellbeing' Brussels,

The role of the National Science Centre in financial support of research The role of the National Science Centre in financial support of research Prof.

HISTORY In 2001, the Ministry of Education initiated the Estonian Programme for Centres of Excellence in Research. The following aims were set up:  to.

Telematikplattform für Medizinische Forschungsnetze (TMF) e.V. TMF – A Common Platform for Medical Research Networks in Germany Improving the Organisation.

Working Together to Work Wonders. The University of Texas Medical Branch Research: Advancing Knowledge, Improving Health David L. Callender, MD, MBA, FACS.

Orphanet Europe State of the Art of Database and Services Polish activity Orphanet Europe State of the Art of Database and Services Polish.

INCONTACT Regional Dialogue Platform(Southeast Asia) Report on the Outputs of the 2-nd Meeting 19 June, 2012, Bonn, Germany Yuriy Zaytsev National Research.

Temporary ESF expert committee on Materials Science and Engineering (MatSEEC) 31st PESC Standing Committee Meeting, April 2010, Helsinki, Finland.

G3 Francophone Academic Alliance. Founding of G3 alliance  Created in September 2012 in Brussels.  Three founding members:  Université de Genève 

EURORDIS Eurordis Position on Research Priorities for Rare Diseases.

Dr. Shane Renwick, DVM, MSc, A/Director, Animal Health Science Division, Canadian Food Inspection Agency CAHLN, UCVM June 8, 2010 Foresight for Canadian.

The ERA-NET TRANSCAN-2, in continuity with the preceding ERA-NET TRANSCAN, aims at linking translational cancer research funding programmes in 15 Member.

JPI - A HEALTHY DIET FOR A HEALTHY LIFE. EUROPE: diversity and fragmentation.

Penn Medicine Arthur H. Rubenstein, MBBCh October 26, ITMAT Symposium.

HORIZON 2020 SC1-Health, demographic change and wellbeing challenge Марина Николовска Министерство за образование и наука

GLOBAL MARKET TRENDS The view from Pharma By Peter Knauer Executive Partner, Alliance Partnership.

Scientific Research Landscape NCP Activity Overview

EHFG 7 October 2005 – Patient Safety & Research UK Presidency Workshop on Patient Safety, EHFG, Bad Hofgastein,7 September 2005 Kevin McCarthy, European.

ERINHA: Framework for the biological high containment research infrastructure STOA – AVIESAN Workshop June 19th 2012, European Parliament, Brussels.

Research and Innovation Research and Innovation Promoting health research and innovation in Horizon 2020 Research and Innovation Research and Innovation.

National Information Day Greece 23 July 2015 Funding priorities under the work plan 2015.

© UEG Presentation by Towards more coordination in health research: a report on the UEG research symposium 16/11/2012 Michael Manns General Assembly.

BioMedical Cluster New opportunities for innovators and investors with Bio-Medical Cluster of Skolkovo Foundation Innovation in Medical Technologies Conference,

Medical and Health research in Norway – in brief Director Mari K. Nes 22 June 2006.

Balancing Objectives and Needs of Industry and Academia: the Role of Government Presentation by Mary Cryan Meeting of National Councils for S&T Policy.

The European Transport Research Alliance - ETRA Prof. G. A. Giannopoulos Chairman, ETRA.

MRC Council Meeting 10 th July 2014 Gateshead Informatics Session Alex Markham University of Leeds Infrastructure for Collaboration: The Leeds MRC Medical.

Evaluation and Impact Assessment of European FP for R&D :

Horizon 2020 – R&D Opportunities

1st China - Belgium Innovation Dialogue R&I landscape and policy in Belgium by Ms Zuhal Demir, State Secretary for Science Policy 30 March,

The NEPG is the largest FREE postgraduate biomedical conference in the UK Student talks and posters: Neuroscience, Immunology, Public Health and Epidemiology,

CENTRES OF EXCELLENCE ESTONIA Prof. Jüri Engelbrecht.

Brussels, 15 September 2009.

UKCRC Translational Infection Research Initiative

Presentation transcript:

The French National Alliance for Life Sciences and Health AVIESAN Prof. André Syrota Chairman and CEO of Inserm President of Aviesan STOA, Brussels, June

The scientific and political context - Changes in the French research and higher education landscape. 2007: The autonomy of the universities. 2009: University Hospitals become research operators. 2011: Investments for the future : 35 billion (2.5 billion for life and health sciences – equipments, cohorts, infrastructures, university hospital institutes, technological research institutes,…) - The scientific challenges of the 21 st century. Biology becoming « an integrative science ». New Health challenges: personalised medicine, ageing, emerging and reemerging diseases, health care systems,… - A complex organisation in Health and Life sciences

The French National Alliance for Life and Health Sciences (Aviesan) 3

4 Aviesan main objectives Scientific coordination Strategic analysis Scientific foresight Programming (National and European levels) Operational coordination Partnership with universities (funding, human resources) Transfer of knowledge Simplification More visibility and reactivity To share priorities on structuring projects

5 Aviesan 10 multi-organization thematic institutes (Itmos) Molecular and structural bases of living organisms Cell biology, development and evolution Genetics, genomics and bioinformatics Immunology, hematology, and pneumology Microbiology and infectious diseases ANRS Public health Health Technologies Neurosciences, cognitive sciences, neurology and psychiatry Alzheimer Cancer INCa Circulation, metabolism, and nutrition

6 Aviesan: Achievements Strategic analysis & scientific foresight Scientific animation Annual conferences, thematic workshops and working groups (H1N1, Nutrition and Cancer, Vaccines, Radiobiology, Environment and Cancer, Epigenetics, Bioinformatics, rare diseases, etc ) Programming National Research Agency (ANR), Thematic agencies within Aviesan Itmos, Investments for the future: research infrastructures European level: JPI, ESFRI BMS, FP7 Health priority, H 2020 Structuring actions H1N1, Research infrastructures, Environment and Health,Synthetic Biology Partnership with Universities Transfer of knowledge

7 Aviesan: Transfer of Knowledge - Annual meeting at the Governmental level Neurosciences, Metabolism and Cardiovascular, Infectious diseases R&D dating - Sanofi Aventis-Aviesan agreement Sponsorship Collaboration agreements Joint funding for project maturation - Covalliance - The epidemiologic portal Strategic Council for health industry: Aviesan as the most appropriate partner

Thank you for your attention 8